Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
[18] [19] The SURMOUNT-1 trial, which assessed tirzepatide for weight management, showed higher rates, with nausea affecting approximately 31% of participants at the 15 mg dose
The choice depends on individual patient factors, including cardiovascular risk, heart failure, chronic kidney disease, and treatment goals
Some patients report that administering injectable GLP-1s in the evening reduces daytime nausea, though this is anecdotal and patients should follow their prescriber's advice
The timing that keeps you most consistent with healthy eating habits will produce the best results
Rotating injection sites between abdomen, thigh, and upper arm prevents localized reactions
Wegovy Weightloss Flextouch Pen 1.7 Mg $295.00 $740.00Price range: $295.00 through $740.00 5.00 out of 5 based on 1 customer rating Wegovy Weightloss Flextouch Pen 1.7 Mg is a once-weekly injectable medication containing semaglutide , a GLP-1 receptor agonist used for chronic weight management in adults with obesity or overweight conditions associated with metabolic risk factors
